onApril 6, 2026

Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.

1 min read

Soleno Therapeutics’ stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy the company.

onApril 6, 2026

3 views

Is the world running out of oil? Here are three ways Goldman Sachs is answering that critical question.

Write a Comment

US, Iran, Mediators In Ceasefire Talks Before Promised Catastrophic Escalation: Axios With a potential globally-catastrophic escalation…

1 Min Read

onMarch 18, 2025

Financial markets are not just focused on what the Federal Reserve says about the future path of interest rates on Wednesday. The markets are…

1 Min Read

onMarch 18, 2025

March Madness numbers to know include $3.1 billion in wagers and nearly $5 million in earnings for one player.